Real World Strategies in Diabetes Patients for LDL-Mediated CV Risk in High Risk Patients Requiring LDL Reduction: Which Agents? In What Sequence? In Which Patient Subsets? A Case-Based Roadmap to Clinical Success - Vivian A. Fonseca, MD, FRCP - Program Co-Chair